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Introduction
Learning disabilities severely deteriorate the life of many NF1 children by limiting their academic achievement, higher education and career choice (1) . However, the pathogenic process for NF1-associated learning disabilities has not been fully understood and an effective therapy is not available. Drs Silva's and Zhong's laboratories have demonstrated that Nf1 mutations lead to the development of learning deficits in mouse and Drosophila, respectively (2) (3) (4) . Their work suggests that Nf1 mutations cause learning deficits by disturbing the Ras/MAPK and/or cAMP signaling. Despite these significant progresses, NF1-affected downstream genes that directly contribute to deficits in synaptic plasticity and learning are largely unknown. We proposed to identify genes that are dysregulated in the hippocampus of the Nf1 +/-mouse model. Characterization of these NF1-affected genes will dramatically improve our understanding of the molecular pathogenesis underlying NF1-associated learning deficits.
Body
During the third year of this project, we focused on following research activities outlined in the Revised Statement of Work approved last year:
Completed microarray data confirmation and bioinformatics analysis (Task 1).
In previous year, we finished DNA microarray experiments with purified RNA from the hippocampus of wild-type and NF1 mice, using Affymetrix GeneChips . In this year, we carried out work in the following two aspects to complete Task 1. (1) . Data confirmation. We performed real-time RT-PCR experiments to confirm our microarray results. The PCR analysis on a group of genes indicated that the expression changes revealed by our DNA microarray analysis are very reliable. (2) . Bioinformatic analysis of NF1-affected genes identified by the DNA microarray analysis. We performed extensive bioinofrmatic analysis on NF1-affected genes, and found that many of them are involved in the regulation of synaptic transmission, synaptic plasticity and memory formation. For example, αCaMKII and CREB1 are disturbed in the NF1 hippocampus. Our findings provide a possible molecular etiologic mechanism for impaired synaptic plasticity and memory of NF1 mice, and probably NF1 patients. 2. Completed DNA microarray analysis on the NF1 hippocampus from mice after lovastatin treatment. Last year, our recommendation to change the Task 2 in the original proposal was approved. In the revised Task 2, we proposed to determine the genomic expression pattern in the NF1 hippocampus after lovastatin treatment, which, as shown by D. Silva's lab, is sufficient to rescue memory deficits of NF1 mice. In this year, we have completed the DNA microarray analysis to compare the genomic expression patterns in the hippocampus of lovastatin-treated NF1 and sham-treated NF1 mice. We found that lovastatin treatment changed the expression of many genes in the NF1 hippocampus. A substantial portion of them are NF1-affected genes. Importantly, we observed reversal effects of lovastatin treatments on the NF1-altered expression of many genes. It would be interesting for future research to determine the role of lovastatin-"corrected" NF1-affected genes in the pathogenesis of NF1 memory deficits.
Key Research Accomplishments
1. Confirmed DNA microarray data and completed bioinformatics analysis on NF1-affected genes. 2. Performed DNA microarray analysis to determine the effect of lovastatin treatment on NF1-affected genes.
Reportable Outcomes
We have submitted a manuscript from this research to report our results outlined above (see attached manuscript). By performing the described research work, two trainees (one postdoctoral fellow and one young research technician) gained experiences in NF1 research.
Conclusions
In summary, we have successfully completed the DNA microarray analysis on the NF1 hippocampus. This analysis has led to the identification of specific NF1-affected genes that are involved in the regulation of synaptic structures and functions. These progresses will facilitate the investigation of the molecular pathways that are disturbed in the NF1 hippocampus and underlie NF1-associated learning disabilities. We also determined the effect of lovastatin on gene expression in the NF1 hippocampus, and identified a group of NF1-affected genes whose abnormal expression in the NF1 hippocampus can be reserved by lovastatin. These findings provide new insights into the molecular abnormalities that probably underlie the pathogenesis of NF1 memory deficits.
ABSTRACT
Neurofibromatosis 1 is (NF1) is a common single-gene disorder that causes learning impairments in patients. Neurofibromin encoded by the NF1 causal gene regulates Ras/MAPK and cAMP signaling pathways. These signaling pathways play critical roles in controlling gene transcription during synaptic plasticity and memory formation. We hypothesized that NF1 mutations disturb the expression of genes important for memory formation. To test this hypothesis, we performed DNA microarray analysis on the hippocampus of NF1 +/-mice, the mouse model for NF1 learning disabilities. Our results indicated that genes involved in a wide spectrum of biological processes are dysregulated in the NF1 +/-hippocampus. Many of the NF1-affected genes play critical roles in synaptic plasticity, such as Rabs, synaptotagmins, NMDAR1, CaMKII and CREB1. We also determined the effect of lovastatin treatment on genomic expression patterns of the NF1 +/-hippocampus. We found that lovastatin altered the expression of a large number of genes, including those disturbed by NF1 mutations. Our results reveal a genomic overview of the molecular abnormalities in the NF1 +/-hippocampus, and should be useful for further identifying the novel molecular pathways that cause NF1 learning deficits.
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INTRODUCTION
Neurofibromatosis 1 (NF1) is a prevailing autosomal dominant genetic disorder that approximately occurs 1 in 3500, and is caused by mutations in a single gene, Nf1 (Eliason, 1988; Cichowski and Jacks, 2001 ). In addition to a variety of physical manifestations including benign and malignant brain tumors, NF1 patients may also experience cognitive difficulties that are often considered as hallmarks of this disease (Hofman et al., 1994; Cichowski and Jacks, 2001 ). Among cognitive impairments associated with NF1, learning disabilities (LD) manifested in 30-65% of NF1 children are especially problematic (Eliason, 1988; North, 1993; North et al., 1995; Ferner et al., 1996; Kayl and Moore, 2000) .
Heterozygous mice with a Nf1 null mutation (Nf1 +/-) develop multiple behavioral phenotypes that bear striking similarities to learning disabilities seen in NF1 patients Costa and Silva, 2003) . For example, as in NF1 patients, Nf1 +/-mice have spatial learning deficits, as suggested by the Morris Water maze test , a learning task that is sensitive to hippocampal lesions. Importantly, similar to NF1 patients, the learning deficits of Nf1 +/-mice can also be compensated by extended training . However, simple associative learning is not affected in both NF1 patients and Nf1 +/-mice .
Similar to NF1 patients, some Nf1 +/-mice do not experience learning impairments . Interestingly, the homozygous knockout mice which carry Nf1 23a-l-mutant genes lacking exon 23a also develop learning deficits even though they are developmentally normal and are without an increased tumor predisposition (Costa et al., 2001 ). This observation indicates that NF1-associated learning impairments are specific phenotypes that can be dissociated from developmental and other physical defects. A variety of studies have suggested that long-term potentiation (LTP) is an important cellular substrate for learning and memory (Grimwood et al., 2001 ). Consistent with this notion, the hippocampus from Nf1 +/-mice also displays deficits in LTP expression ).
The neurofibromin protein encoded by the Nf1 gene is a tumor suppressor related to Ras
GTPase-activating proteins (GAP) (Cichowski and Jacks, 2001; Zhu and Parada, 2001a; Weeber and Sweatt, 2002) . As a Ras GAP-related protein, neurofibromin functions as a negative regulator of Ras function, by accelerating the hydrolysis of GTP to GDP that leads to inactivation of Ras (Cichowski and Jacks, 2001; Zhu and Parada, 2001a; Weeber and Sweatt, 2002) . Previous studies indicated that the abnormal up-regulation of the Ras activity after lossof-function of neurofibromin is a crucial step leading to learning impairments in Nf1 +/-mice . Down-regulation of Ras activities in Nf1 +/-mice by genetic and pharmacological approaches rescued learning deficits and LTP deficits .
Drosophila neurofibromin not only is a Ras-GAP (Williams et al., 2001 ) but also regulates the cAMP signaling (Guo et al., 1997; The et al., 1997; Tong et al., 2002) .
Mutations of Drosophila Nf1 likely impair learning by inhibiting the cAMP/PKA signaling pathway . A role of mammalian neurofibromin in regulating adenylyl cyclase has also been reported (Tong et al., 2002) . As both Ras/MAPK and cAMP signaling cascades play important roles in regulation of gene expression during synaptic plasticity and memory formation, their disturbance likely dysregulates gene expression in specific brain regions such as the hippocampal formation, where neurofibromin is highly expressed (Nordlund et al., 1995; Zhu and Parada, 2001b) . However, NF1-affected genes that contribute to the pathogenesis of learning deficits have not been identified.
We have used DNA microarrays to identify genes that alter their expression in the hippocampus Nf1 +/-mice. A comprehensive pool of NF1-affected hippocampal genes that function in a wide spectrum of biological pathways is identified. Many of them are known to involve in synaptic plasticity and memory formation. In addition, we also characterized genes that respond to lovastatin treatment. These findings provide a genomic overview of the molecular pathogenic abnormalities that are likely relevant to NF1 learning deficits.
RESULTS

NF1 +/-mice develop reversible deficits in consolidation but not in encoding of fear memories.
We first investigated the learning performance of NF1 +/-mice on a contextual discrimination task . In this hippocampal-dependent learning task, mice were trained in two chambers; one of them was associated with electric shocks (shock chamber) and another was not (control chamber). The expression of freezing behaviors was determined to measure fear memories ( Fig. 1 ). On the training day, NF1 +/-and wild-type mice were indistinguishable in both chambers (Fig. 1A) . One day after training, both NF1 +/-and wild-type mice showed clear increases of freezing behaviors in the shock chamber but not in the control chamber, indicating formation of the contextual-shock association. At this stage, the percentage of freezing developed in NF1 +/-mice was not significantly different from that of wild-type mice (p>0.05) (Fig. 1B ). This observation indicates that the NF1 +/-mice are normal during the encoding phase of fear memories. Consistent with this notion, previous work also suggested that NF1 +/-mice are not impaired during the acquisition phase in the Morris Water Maze task . On the other hand, memory tests on day 7 showed that the percentage of freezing of NF1 +/-mice was significantly lower than that of wild-type mice (Fig. 1C ). These observations suggest that NF1 +/-mice are impaired in memory consolidation between day 2 and 7 after training. To test whether this memory deficiency of NF1 +/-mice can be compensated by more training, we added one more session of contextual-shock pairing in the shock chamber at day 1 after the initial training. Memory tests at day 7 showed that, after reinforced training at day 1, NF1 +/-and wild-type mice developed similar amounts of freezing ( Fig. 1D ). This result indicates that the deficiency in contextual fear memory of NF1 +/-mice can be compensated by excess training. This observation supports the notion from previous studies in the Morris Water Maze task .
DNA microarray analysis of the NF1 +/-hippocampus.
Results described above and previously ) strongly suggest a specific impairment of NF1 +/-mice in consolidation of hippocampal-dependent memory. To obtain insight into the molecular basis of NF1-associated memory impairments, we sought to determine the genomic expression of the NF1 +/-hippocampus. We performed DNA microarray analysis to identify genes that were aberrantly expressed in the NF1 +/-hippocampus from male mice at 2 month of age, using Affymetrix GeneChip (MG430v2) that contains over 39000 probe sets.
Four independent array replicates with RNAs from different mice were included. Visualization of microarray data in a distribution scatter plot revealed that the expression levels of some genes were shifted in the NF1 +/-hippocampus ( Fig. 2) . T-tests with Cyber-T (Hung et al., 2002) (http://visitor.us.uci.edu/genex/cybert/) identified 6418 probes that were significantly changed in the NF1 +/-hippocampus (p<0.05) (Supplemental Table 1 ). We performed real-time RT-PCR analysis to confirm the expression changes of a group of genes ( Fig. 3 ).
Diverse molecular and cellular processes are disturbed in the NF1 +/-hippocampus. (Cavallaro et al., 2002) . Thus, it is likely that there is a globe disturbance of genes in cellular and molecular processes underlying memory formation in the hippocampus of NF1 +/-mice.
Dysregulation of synapse-related genes in the NF1 +/-hippocampus.
Synapses are the structural units for information storage. We next sought to determine whether synapse-related genes are disturbed in the NF1 +/-hippocampus. By searching the PubMed database on the NF1-affected genes (p<0.05), we found that 213 were synapse-related (Fig. 4A) . 103 of them were aberrantly downregulated and 110 up-regulated. Hierarchical clustering of these synapse-related genes showed that many of the synapse-related genes were consistently dysregulated in the NF1 +/-hippocampus from different animals (Fig. 4) .
Dysregulation of these genes may be a reliable biomarker of the NF1 +/-hippocampus.
Of the synapse-related genes dysregulated in the NF1 +/-hippocampus, many of them are involved in neurotransmitter vesicle trafficking/recycling (Table 2 ). These include Rab and synaptotagmin proteins, such as Rab1, Rab2, Rab3A, and synaptotagmin1 (Table 2; Supplemental Table 1 ). In addition, the expression of several synaptic receptor genes, including NMDA receptor 1, AMPA receptor 4 and metabotropic glutamate receptor 5 (mGluR5), was altered ( Table 2 ; Supplemental Table 1 ). These observations indicate that genes critical for neurotransmission are disturbed in the NF1 +/-hippocampus. Furthermore, a number of genes encoding synaptic structural proteins, such as neurexin1, integrin β6, integrin β7 and Ncam1, were disturbed (Table 2 ; Supplemental Table 1 ). We also observed that genes encoding CaMKII and other important synaptic signaling proteins were dysregulated in the NF1 +/-hippocampus ( Table 2 ). The altered expression of the genes involved in the regulation of neurotransmission, structures and signaling of the synapse potentially contributes to the observed impairments of synaptic function and plasticity .
Disturbance of LTP-regulated genes in the NF1 +/-hippocampus.
Long-term potentiation (LTP) is widely considered as a critical cellular mechanism underlying memory formation. We hypothesized that specific LTP-related genes are disturbed in the NF1 +/-hippocampus. To test this idea, we compared the activity-regulated genes (ARGs) that changed their expression after LTP induction (Park et al., 2006) with those that were disturbed in the NF1 +/-hippocampus (Supplemental Table 1 ). We found that 121 ARGs were dysregulated in the NF1 +/-hippocampus (Fig. 4B ). Of these ARGs, 71 were abnormally downregulated and 50 upregulated in the NF1 +/-hippocampus. This finding indicates that the LTP-related processes associated with these ARGs are disturbed in the NF1 +/-hippocampus. The malfunction of these processes may contribute to the LTP impairments in the NF1 +/-hippocampus . Among the LTP-related genes that are dysregulated in the NF1 +/-hippocampus are αCaMKII and CREB1 (Table 2 ; Supplemental Table 1 ).
Lovastatin treatment of NF1 +/-mice changes genomic expression patterns in the hippocampus.
A recent exciting study showed that treatment with lovastatin improved the learning performance of NF1 +/-mice. Therefore, we sought to determine the effects of lovastatin treatment on the genomic expression in the NF1 +/-hippocampus. We performed DNA microarray analysis to compare the hippocampal genomic expression of NF1 +/-mice received 4 days of lovastatin treatment, which was effective to rescue memory deficits , with that of control NF1 +/-mice received sham (vehicle) treatment. We found the expression level of 2976 probe sets was altered by lovastatin treatment at p<0.05 and 682 genes at p<0.01. GO analysis indicated that the lovastatin-altered genes were involved in many biological processes, including cell-cell communication, cell signaling, transcription and cytoskeleton dynamics (Table 3 ). The results suggest that lovastatin affect genes in diverse biological processes that are disturbed in the NF1 +/-hippocampus (Table 1) . Of the NF1-disturbed genes (p<0.05), 377 changed their expression level after lovastatin treatment. We observed that lovastatin reversed the aberrant expression of some NF1-affected genes ( Fig. 5A; Fig. 5B ). For some other NF1-affected genes, lovastatin treatment caused further aberrant expression ( Fig. 5C; Fig. 5D ).
Next, we examined whether lovastatin affected activity-regulated genes (ARGs) that are regulated by LTP induction. We reasoned that lovastatin-induced memory improvement of NF1 +/-mice may be accompanied by the reversal of the abnormal expression of some ARGs. To this end, we compared ARGs (Park et al., 2006) with the genes that are NF1-disturbed and lovastatin-regulated, and found that 210 NF1-disturbed ARGs were regulated by the lovastatin treatment (p<0.05) (Supplemental Table 3 ).
DISCUSSION
Neurofibromin negatively regulates MAPK signaling via Ras (Cichowski and Jacks, 2001 ). Therefore, NF1 mutations cause aberrant activation of MAPK signaling (Cichowski and Jacks, 2001 ). Previous studies have suggested an important role of MAPK signaling in regulating gene expression during synaptic plasticity and memory formation (English and Sweatt, 1997; Orban et al., 1999; Atkins et al., 2000; Davis et al., 2000; Thomas and Huganir, 2004) . Hence, it is reasonable to hypothesize that abnormally expressed genes caused by NF1-mediated MAPK signaling activation underlie NF1-associated memory impairments. Consistent with this view, our studies indicate that NF1 mice are specifically impaired in memory consolidation but not encoding (acquisition) (Fig.1 ).
Functional assignment of NF1-affected hippocampal genes indicates that they are involved in a broad spectrum of molecular and cellular processes, including cell-cell communication, signal transduction, transcription and cytoskeleton dynamics (Table 1 ). Many genes in these biological pathways have been shown to be regulated during synaptic plasticity and memory formation (Cavallaro et al., 2002; Levenson et al., 2004; Park et al., 2006) . It is not clear at this stage whether the NF1 memory deficits are caused by the disturbance of one or multiple of these pathways. Nonetheless, the identified NF1-affected hippocampal genes provide a basis for further characterization of the specific processes that are causally relevant to the development of NF1 memory impairments.
We found that the expression of many genes encoding proteins involved in synaptic transmission is altered in the NF1 hippocampus ( Table 2 ). These include proteins that are involved in regulation of synaptic vesicle recycling, such as Rabs, synaptotagmins and
dynamins. An interesting feature is the bidirectional regulation of different members of the same protein family. For example, Rab1 and Rab2 are downregulated in the NF1 hippocampus, while
Rab3A is upregulated; Synaptotagmin 1 is downregulated, while synaptotagmin7 is upregulated; Dynamin 2 is upregulated, while dynamin 3 is downregulated. It is intriguing to think that the bidirectional regulation of different members in the same protein family may provide a homeostatic mechanism to compensate the primary defects caused by NF1 mutation. In addition, the expression of glutamate receptors is also disturbed. For instance, NMDADR1 is downregulated, while AMPAR4 and mGluR5 are upregulated. Previous studies revealed a deficit of synaptic transmission in NF1 mice, which was considered to be caused by enhanced inhibition . Our findings reveal a disturbance of molecular processes underlying synaptic vesicle recycling; it would be interesting to determine whether these molecular disturbances contribute to the observed impairments of synaptic transmission.
Synaptic plasticity are thought to be accompanied by synapse remodeling (Engert and Bonhoeffer, 1999; Toni et al., 1999; Yuste and Bonhoeffer, 2001; Matsuzaki et al., 2004) . We observed that some cytoskeleton regulatory genes are disturbed in the NF1 +/-hippocampus (Table 1 ). In addition, we found that, in the NF1 +/-hippocampus, the expression of many genes encoding synaptic structural protein genes is altered. For example, integrinβ7, NCAM1 and transglutaminase2 are upregulated, whereas integrinβ6 and neurexin1 are downregulated ( Table   2 ). The involvement of these classes of proteins in LTP has been demonstrated (Sanes and Lichtman, 1999; Park et al., 2006) . Our findings suggest that synapse remodeling underlying synaptic plasticity may be dysregulated in the NF1 +/-hippocampus.
The expression of long-term synaptic plasticity is controlled by synaptic signaling. The αCaMKII protein is one of the key signaling proteins that are enriched at synapses and critical for synaptic plasticity and memory formation (Lisman et al., 2002) . Interestingly, in the NF1 +/-hippocampus, αCaMKII gene is downregulated ( Table 2 ). On the other hand, CaMKIIβ, which interacts with αCaMKII to form a holoenzyme, is upregulated (Table 2) . Other signaling protein genes that are important for synaptic plasticity and disturbed in the NF1 +/-hippocampus include CDK5 (Table 2 ) (Angelo et al., 2006) . A major mechanism by which synaptic signaling regulates synaptic plasticity is to control gene transcription. CREB is a transcription factor that plays an important role in long-lasting synaptic plasticity and memory consolidation . Interestingly, CREB1 expression is decreased in the NF1 +/-hippocampus ( Table 1 ). The downregulation of CREB1 expression may contribute to the deficiency of memory consolidation in NF1 +/-mice (Fig. 1 ).
Recent studies demonstrated that lovastatin suppresses MAPK activity and rescues memory deficits of NF1 mice . We found that lovastatin treatment of NF1 mice for 1 week, which was sufficient to rescue memory deficits , changed the expression of many genes in different functional groups (Table 3) ; some of them are synaptic plasticity-related genes. However, lovastatin-regulated genes are not significantly enriched with NF1-affected genes. It is not clear at this stage whether lovastatin rescues NF1 memory deficits via reversing aberrant genomic expression. 
MATERIALS AND METHODS
Nf1
Contextual discrimination
Eight week old mice were used for the contextual discrimination behavioral tests, which were performed as described . All experiments were carried out blind with respect to genotypes. Two contextually different chambers, one for training with mild electric shocks (S) and another for control (C), were used in these behavioral tests. Chambers S and C were located in the same room and housed in separate sound-attenuated boxes. Three days prior to training, animals were handled daily for 5 minutes and allowed to freely explore both chambers S and C for 5 minutes (pre-exposure). On training day, in chamber S, animals were allowed to explore for 2.5 minutes before a 2 second 0.8 mA foot-shock was delivered.
Mice were then observed for an additional 30 seconds before being returned to their home cages.
In chamber C, mice were allowed to explore for 3 minutes, without shocks, and then returned to their home cages. Contextual fear memory was measured by scoring freezing behaviors during the first 2.5 minutes of exploration immediately after the mouse was placed in a chamber. 
Lovastatin treatment
Lovastatin (mevinolin, Sigma-Aldrich) in the lactone form was dissolved in 55ºC ethanol and then NaOH was added (1M). The solution was left at room temperature for 30 minutes to complete the conversion of lovastatin to the sodium salt. The final lovastatin solution (4mg/ml) was adjusted to pH7.5 with HCl. Mice were injected with 10mg/kg of lovastatin or the vehicle control subcutaneously once per day for 4 days. On the 4th day, 6 hours following the final injection, mice were sacrificed to collect the hippocampus for RNA extraction.
Tissue collection / RNA extraction
Whole hippocampi were dissected and collected, with one hippocampus immediately used for RNA extraction and the other flash-frozen and stored at -80 ºC for additional RNA extraction or other assays. Total RNA was extracted from fresh, whole hippocampus using the RNeasy kit (Qiagen). The hippocampus was first homogenized in lysis buffer (supplied with the RNeasy kit) for 30 seconds using a mortar and pestle. The lysate was then centrifuged through a
QIAshredder column (Qiagen) to further homogenize the tissue. RNA was extracted using the RNeasy kit following the manufacturer's directions. The extracted total RNA was flash-frozen and stored at -80 ºC.
Microarray analysis
Microarray processing and hybridization was performed by the University of California, Irvine DNA Core Facility. Prior to processing for microarray hybridization, the quality of each 
Nf1
+/-mice with WT control mice was performed using CyberT, which performs t-tests that incorporate a Bayesian estimate of the variance of the microarray expression data to compensate for a low number of experimental replicates (http://visitor.ics.uci.edu/genex/cybert/). Genes that were differentially expressed between Nf1 +/-and WT control mice at statistically significant levels (p<0.05) were identified and compiled in list for further analysis. Hierarchical clustering of expression profiles of Nf1 +/-and WT control mice was performed using dChip and GeneSpring (Silicon Genetics).
Real-time quantitative RT-PCR verification
Real 
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